Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Russel Ruo"'
Autor:
Marie Duclos, Russel Ruo, Fabio Cury, Luis Souhami, Sergio Faria, Arash Sarshoghi, Marianna Perna
Publikováno v:
Practical Radiation Oncology. 10:e514-e520
Purpose Moderate hypofractionated radiation therapy (HypoRT) is an attractive alternative to conventionally fractionated radiation therapy for prostate cancer. However, most studies using HypoRT only included the prostate as the target volume. We rep
Autor:
Richard S. Fraser, Areej Al-Rabea, Jan Seuntjens, Bassam Abdulkarim, Ayman Oweida, Mojgan Ebrahimi, Russel Ruo, Siham Sabri
Publikováno v:
Oncotarget
Stereotactic ablative radiotherapy (SABR) is the main treatment for inoperable early-stage non-small cell lung cancer (NSCLC). Despite the widespread use of SABR, the biological determinants of response to SABR remain poorly investigated. We develope
Publikováno v:
Practical Radiation Oncology. 7:264-269
Purpose To report acute and late toxicity rates in patients with high-risk prostate cancer treated with androgen deprivation therapy (ADT) and moderate hypofractionated radiation therapy (HypoRT) to the prostate and nodal areas. Methods and materials
Publikováno v:
Radiotherapy and Oncology. 139:S94
Autor:
Jean Deschênes, Ahmed Shaban, Christine Corriveau, Alan Dal Pra, Kitty Shun, Rolina Al-Wassia, Chaim Edelstein, François DeBlois, Russel Ruo, Horacio Patrocinio, Fabio Cury, George Shenouda
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 81:e455-e462
To report our experience with linear accelerator-based stereotactic fractionated radiotherapy in the treatment of juxtapapillary choroidal melanoma.We performed a retrospective review of 50 consecutive patients diagnosed with juxtapapillary choroidal
Publikováno v:
Practical radiation oncology. 5(6)
Purpose To evaluate the displacement of the pelvic lymph node (PLN) target when using cone beam computed tomography (CBCT) for localization of the prostate in patients treated with simultaneous integrated boost. Methods and materials High-risk prosta
Publikováno v:
Journal of Clinical Oncology. 35:47-47
47 Background: Two recent large randomized trials confirm that 60Gy in 20 fractions is an effective regimen compared to conventionally fractionated escalated doses in localized prostate cancer. However, in these two trials the prostate was the only t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.